Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.
about
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic ImplicationsBiphasic mechanisms of neurovascular unit injury and protection in CNS diseasesNeuroantibody biomarkers: links and challenges in environmental neurodegeneration and autoimmunityDrug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?Neurovascular abnormalities in brain disorders: highlights with angiogenesis and magnetic resonance imaging studies.Functional brain networks in movement disorders: recent advancesEffects of levodopa on regional cerebral metabolism and blood flowStriatal blood-brain barrier permeability in Parkinson's disease.Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's disease.Increased CSF biomarkers of angiogenesis in Parkinson diseaseMetabolic brain networks in translational neurology: concepts and applications.L-DOPA Uptake in Astrocytic Endfeet Enwrapping Blood Vessels in Rat Brain.Temporal effects of vascular endothelial growth factor and 3,5-cyclic monophosphate on blood-brain barrier solute permeability in vivo.Primary culture of mouse dopaminergic neurons.Flow-metabolism dissociation in the pathogenesis of levodopa-induced dyskinesiaThe role of β-adrenergic blockers in Parkinson's disease: possible genetic and cell-signaling mechanisms.Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease.Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.Supplementation of complex milk lipid concentrate (CMLc) improved the memory of aged rats.Endogenous recovery after brain damage: molecular mechanisms that balance neuronal life/death fate.Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular unitsCerebrospinal fluid biomarkers for Parkinson's disease - a systematic review.Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l-DOPA treatment and changes in levodopa-induced dyskinesia.l-DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?l-DOPA-induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?Vascular inter-regulation of inflammation: molecular and cellular targets for CNS therapy.Insights into the Mechanisms Involved in Protective Effects of VEGF-B in Dopaminergic Neurons.Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model.Levodopa-induced abnormal involuntary movements correlate with altered permeability of the blood-brain-barrier in the basal ganglia.Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia.Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
P2860
Q21129423-D9BB8143-EE0D-46FE-A7C1-0C372201226FQ26827146-86781946-5391-47B6-B6A9-10719F8704F0Q27010245-595499D3-97AA-46E6-88A7-4DA8871374FCQ27021464-6FE78ABF-F2DC-44B2-9495-A52CF5E9DA34Q30653662-460FBAD1-1F7C-4D3F-9F49-1B07510E0959Q34308197-B9FDED36-E8B4-43DC-BAF1-50792041CB73Q35040119-0536BAF8-0C38-4602-8FFE-A8E4FFBDE2DCQ35572836-B6AC70CC-1CC7-4A43-A9A2-8CB5D7869497Q35683102-FC29243D-D7EA-4F0C-AF2B-E82F8596FDA0Q35825166-F162E9F7-164A-4D3F-8C52-6602F458848CQ36041821-96057FE0-1D44-495A-A807-3A0A23A07705Q36131925-54A23A2E-876C-421F-9C2D-4FBACD99A437Q36407801-C7B18768-1795-4975-BDCC-A15CEC423B4DQ36788096-A8F23A00-CBF1-486F-A7FF-9AD3D15816FAQ37277039-4D09812B-A84B-45AE-A487-3A3DF1A9DCFEQ38108496-25829EF9-6731-400D-AEBF-E3949E957B08Q38241183-A89EBDEE-04E3-42D6-AEB5-45938219BAF2Q38262418-946806DE-CAAA-42C1-A975-EC655C88798CQ38444479-2B6D6820-F351-483B-A3EC-712C86CA1F85Q38587925-23983F6B-AF91-46B7-9BDA-8EBA438B146AQ38751291-54A9A8D8-7638-44BA-9AED-07BEC853ACE9Q38780220-4906F405-F4A0-4846-AA54-987DF9AEBADCQ38937893-08313B92-0479-4AFF-AF96-93D21F392902Q38951947-EE8E9FD3-C61E-4465-BA5A-9AD394964DEDQ39012371-157FE934-304A-4D00-BD25-41001680EC85Q39031301-A4098FD8-256B-474C-99E8-F6A0B496D749Q39284965-6BE0634F-F8FE-49E2-955E-10FF48BC7D18Q39470500-CC91EE22-6948-46E5-A4B6-3444651DE66EQ47116959-58B4A206-A611-4E9F-AA6B-D0FEB507C069Q47442360-666CAC19-D4D3-49C1-9A04-963D98B353C7Q48345542-9B87408F-45A7-4FBF-8A76-F4D44D2E2031Q48956010-EED77E4C-4B07-42E7-8D6B-31ED67733B10Q50091410-5B82152D-9BE9-4AA7-8F23-35295D2FB2A9Q59136331-5E8A16E7-B32D-4895-B0FD-7B13210998B9
P2860
Vascular endothelial growth factor is upregulated by L-dopa in the parkinsonian brain: implications for the development of dyskinesia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Vascular endothelial growth fa ...... the development of dyskinesia.
@ast
Vascular endothelial growth fa ...... the development of dyskinesia.
@en
type
label
Vascular endothelial growth fa ...... the development of dyskinesia.
@ast
Vascular endothelial growth fa ...... the development of dyskinesia.
@en
prefLabel
Vascular endothelial growth fa ...... the development of dyskinesia.
@ast
Vascular endothelial growth fa ...... the development of dyskinesia.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Vascular endothelial growth fa ...... the development of dyskinesia.
@en
P2093
Andrew S Luksik
Christine Konradi
Hanna S Lindgren
M Angela Cenci
Sean S O'Sullivan
Stephanie E Sillivan
P2860
P304
P356
10.1093/BRAIN/AWR165
P407
P577
2011-07-19T00:00:00Z